<DOC>
	<DOCNO>NCT00003219</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness perillyl alcohol treat patient metastatic breast cancer respond previous chemotherapy .</brief_summary>
	<brief_title>Perillyl Alcohol Treating Patients With Metastatic Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine clinical effectiveness ( i.e. , objective tumor response , time treatment failure , survival ) perillyl alcohol patient previously treat metastatic breast cancer . II . Define acute chronic toxic effect perillyl alcohol patient population . OUTLINE : Patients give oral perillyl alcohol 4 time per day . Dose escalation perillyl alcohol may occur individual patient unacceptable toxicity observe . Treatment continue long patient benefit treatment , show progressive disease , experience irreversible life threaten toxicity . Patients evaluated response monthly receiving treatment study . Patients follow 2-4 week last treatment . PROJECTED ACCRUAL : Approximately 40 patient accrue 2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Perilla alcohol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Microscopically confirm metastatic breast cancer Must refractory recur least 1 systemic chemotherapy regimen Estrogen receptor positive tumor must fail recurred hormonal therapy At least 1 site measurable disease require Previously radiate lesion consider measurable unless evidence disease progression completion radiation therapy No known brain metastases Hormone receptor status : Unspecified PATIENT CHARACTERISTICS : Age : 18 Menopausal status : Not specify Performance status : Zubrod 02 Life expectancy : At least 12 week Hematopoietic : WBC least 4000/mm3 Platelet count least 100,000/mm3 Absolute neutrophil count least 1500/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT great 2 time normal Renal : Creatinine great 1.5 mg/dL BUN great 30 mg/dL Other : Effective birth control must use fertile patient ( barrier method prefer ) Not pregnant nursing PRIOR CONCURRENT THERAPY : Recovered toxic effect prior treatment Biologic therapy : No immunologic therapy within past 2 week Chemotherapy : No chemotherapy within past 4 week ( 6 week mitomycin nitrosoureas ) See Disease Characteristics Endocrine therapy : No hormonal therapy within past 2 week See Disease Characteristics Radiotherapy : No radiotherapy within past 4 week See Disease Characteristics Surgery : Not specify Other : No concurrent cholesterol lower agent , supplemental vitamin , antioxidant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
</DOC>